References
1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. The Lancet. 2016;388(10055):2023-38.
2. Tilstra JS, Lienesch DW. Rheumatoid nodules. Dermatologic clinics. 2015;33(3):361-71.
3. Jagadeesan S, Shenoy P. Arthropathy in dermatology: A comprehensive review. Indian dermatology online journal. 2017;8(2):79.
4. Levin J, Werth VP. Skin disorders with arthritis. Best Practice & Research Clinical Rheumatology. 2006;20(4):809-26.
5. Paget SA. Rheumatoid arthritis (RA) is a chronic systemic autoimmune and in-flammatory disorder of unclear etiology. It is characterized by a sym-metric polyarthritis, which is often erosive, resulting in irreversible damage to the joints. Although the musculoskeletal manifestations usually dominate the clinical picture, extra-articular manifestations are also common and on rare occasions can be life-threatening. RA is the most common immune-mediated inflammatory arthropathy, with a prevalence of up to 1.5% in North America. In some Native-American populations, the preva-lence may exceed 5%. Expert Guide to Rheumatology. 2005:29.
6. Akdeniz N, Çalka Ö, Bilgili SG, Bayram İ. A Case of Rheumatoid Neutrophilic Dermatosis. Journal of the Turkish Academy of Dermatology. 2008;2(4).
7. Lazarov A, Mor A, Cordoba M, Mekori YA. Rheumatoid neutrophilic dermatitis: an initial dermatological manifestation of seronegative rheumatoid arthritis. Journal of the European Academy of Dermatology and Venereology : JEADV. 2002 Jan;16(1):74-6. PubMed PMID: 11952297.
8. Chua-Aguilera CJ, Möller B, Yawalkar N. Skin manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritides. Clinical reviews in allergy & immunology. 2017;53(3):371-93.
9. Hata T, Kavanaugh A. Rheumatoid arthritis in dermatology. Clinics in dermatology. 2006;24(5):430-7.
10. Bevin AA, Steger J, Mannino S. Rheumatoid neutrophilic dermatitis. Cutis. 2006 Aug;78(2):133-6. PubMed PMID: 16983904.
11. Lee HH, Song IH, Friedrich M, Gauliard A, Detert J, Röwert J, et al. Cutaneous side‐effects in patients with rheumatic diseases during application of tumour necrosis factor‐α antagonists. British Journal of Dermatology. 2007;156(3):486-91.
12. Marcucci E, Bartoloni E, Alunno A, Leone M, Cafaro G, Luccioli F, et al. Extra-articular rheumatoid arthritis. Reumatismo. 2018;70(4):212-24.
13. MATSUSHITA M, YAMAJI K, TAMURA N. Extra-articular Manifestations of Rheumatoid Arthritis. Juntendo Medical Journal. 2020;66(1):21-6.
14. Zuk G, Jaworecka K, Samotij D, Ostanska E, Reich A. Rheumatoid neutrophilic dermatitis. Reumatologia. 2019;57(6):350-3. PubMed PMID: 32226170. Pubmed Central PMCID: 7091481.
15. Below J, Helbig D. [Rheumatoid neutrophilic dermatitis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2015 Apr;66(4):228-30. PubMed PMID: 25757837. Rheumatoide neutrophile Dermatitis.
16. Ergun T, Inanc N, Tuney D, Kotiloglu EK, Seckin D, Tetik C, et al. Skin manifestations of rheumatoid arthritis: a study of 215 Turkish patients. International journal of dermatology. 2008;47(9):894-902.
17. Alavi A, Sajic D, Cerci FB, Ghazarian D, Rosenbach M, Jorizzo J. Neutrophilic dermatoses: an update. American journal of clinical dermatology. 2014;15(5):413-23.
18. Çetin GY, Sayarlıoğlu H, Erhan Ç, Kahraman H, Cıralık H, Sayarlıoğlu M. A case of neutrophilic dermatosis who develop palpable purpura during the use of montelukast. European journal of rheumatology. 2014;1(4):170.
19. Kumari I, Dongre A, Mohanty S. Rheumatoid Neutrophilic Dermatosis: The Distinct Entity with Florid Presentation. Indian dermatology online journal. 2020 Jan-Feb;11(1):114-5. PubMed PMID: 32055526. Pubmed Central PMCID: 7001406.
20. Wijenayake BK. Neutrophilic Dermatoses. Atlas of Dermatoses in Pigmented Skin: Springer; 2021. p. 213-23.